Cargando…
Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer—A RADIOSA Trial Preliminary Analysis
(1) Background: In the RADIOSA phase II randomized clinical trial (NCT03940235), the biology task entails the identification of predictive and prognostic biomarkers in the context of oligorecurrent, castration-sensitive prostate cancer in order to distinguish polymetastatic from oligometastatic dise...
Autores principales: | Zaffaroni, Mattia, Vincini, Maria Giulia, Corrao, Giulia, Lorubbio, Chiara, Repetti, Ilaria, Mastroleo, Federico, Putzu, Costantino, Villa, Riccardo, Netti, Sofia, D’Ecclesiis, Oriana, Luzzago, Stefano, Mistretta, Francesco Alessandro, Musi, Gennaro, Cattani, Federica, Gandini, Sara, Marvaso, Giulia, Jereczek-Fossa, Barbara Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647217/ https://www.ncbi.nlm.nih.gov/pubmed/37960236 http://dx.doi.org/10.3390/nu15214583 |
Ejemplares similares
-
Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
por: Marvaso, Giulia, et al.
Publicado: (2019) -
Automatic Segmentation with Deep Learning in Radiotherapy
por: Isaksson, Lars Johannes, et al.
Publicado: (2023) -
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
por: Zaffaroni, Mattia, et al.
Publicado: (2022) -
Prognostic Impact of Sarcopenia’s Occurrence during Radiotherapy in Oropharyngeal Cancer Patients
por: Bergamaschi, Luca, et al.
Publicado: (2023) -
Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy
por: Corrao, Giulia, et al.
Publicado: (2023)